Drug intelligence / Profile preview

Relispray Nitron

Development stage
Unknown
Lead developer
Midas Care
Modality
Small Molecules
Administration
Topical
01

Overview

Relispray Nitron is a topical analgesic aerosol spray developed by Midas Care, specifically formulated to provide immediate cryotherapy (cold therapy) for acute pain relief. Marketed as an "ice-cold spray," it is primarily indicated for sports injuries, sprains, strains, and muscle impact injuries. The product works by rapidly lowering the skin temperature upon application, mimicking the physiological effects of an ice pack to reduce localized inflammation, edema, and pain. Its formulation typically includes cooling agents such as menthol, which activates cold-sensitive TRPM8 receptors, and methyl salicylate (derived from wintergreen oil), which provides local anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes. Relispray Nitron is designed for quick absorption and instant symptomatic relief in emergency or athletic settings.

Brand names
Relispray Nitron
Other names
Relispray Nitron Ice Cold Spraycold therapy pain relief
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Relispray Nitron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relispray Nitron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call